Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
MF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.32.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.47.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.529 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.41.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.14.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.14.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.17.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used